We are pleased to announce the appointment of Kristel Senten and Joeri Veiro as two new Directors, bringing fresh strength to KELA’s Direction Committee and enriching our expertise in R&D and Operations.
Together with Pascal Beyens CEO and Bart Lavrysen CFO, these new members will further reinforce and balance our management team. Their arrival reflects our shared ambition to remain a strong, high‑performing organization, fully aligned with KELA’s mission to deliver high‑quality veterinary medicines and solutions that promote animal health and welfare worldwide.
We warmly welcome Kristel and Joeri in their new roles and look forward to shaping a stronger, future-ready KELA together
